Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes

Biochemistry

Volumn 49, Issue 44, 2010, Pages 9508-9517

  Li, Hongzhe ^a   Zhao, Yulan ^b   Zhou, Shuli ^a   Heng, Chew Kiat ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEINS; ADIPOGENESIS; BACTERIAL INFECTIONS; CHOLESTEROL EFFLUX; CHOLESTEROL TRANSPORT; DOWNSTREAM TARGET; EXTRACELLULAR; EXTRACELLULAR- SIGNAL-REGULATED KINASE 1/2; HEPATOCYTES; HEPG2 CELLS; LIPID DEPOSITION; LIPID METABOLISMS; NATURAL LIGANDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PRE-INCUBATION; REGULATED KINASE; SERUM AMYLOID A; THERAPEUTIC TARGETS; TISSUE DAMAGE; TISSUE REPAIR; TRANSCRIPTIONAL ACTIVITY;

BODY FLUIDS; CHOLESTEROL; CYTOLOGY; ENZYME ACTIVITY; GLYCOPROTEINS; PATHOLOGY; PROTEINS;

GENE EXPRESSION;

CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SERUM AMYLOID A;

ADIPOGENESIS; ARTICLE; CELL STRAIN HEPG2; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHOLESTEROL; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR GAMMA; PROSTAGLANDIN D2; SERUM AMYLOID A PROTEIN; TRANSCRIPTIONAL ACTIVATION;

BACTERIA (MICROORGANISMS);

EID: 78149332813     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi100645m     Document Type: Article

References (44)

1. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., Nichol, G., O'Donnell, C., Roger, V., Sorlie, P., Steinberger, J., Thom, T., Wilson, M., and Hong, Y. (2008) Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117, e25-e146
2. Ross, R. (1999) Atherosclerosis: An inflammatory disease N. Engl. J. Med. 340, 115-126
3. Kisilevsky, R. and Tam, S. P. (2002) Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease Pediatr. Pathol. Mol. Med. 21, 291-305
4. Urieli-Shoval, S., Cohen, P., Eisenberg, S., and Matzner, Y. (1998) Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium J. Histochem. Cytochem. 46, 1377-1384
5. Malle, E. and De Beer, F. C. (1996) Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice Eur. J. Clin. Invest. 26, 427-435
6. Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H. C., Jeenah, M. S., and de Beer, F. C. (1986) Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition J. Biol. Chem. 261, 9644-9651
7. Banka, C. L., Yuan, T., de Beer, M. C., Kindy, M., Curtiss, L. K., and de Beer, F. C. (1995) Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux J. Lipid Res. 36, 1058-1065
8. Kisilevsky, R., Tam, S. P., and Ancsin, J. B. (2008) The anti-atherogenic potential of serum amyloid A peptides Curr. Opin. Invest. Drugs 9, 265-273
9. von Eckardstein, A., Hersberger, M., and Rohrer, L. (2005) Current understanding of the metabolism and biological actions of HDL Curr. Opin. Clin. Nutr. Metab. Care 8, 147-152
10. Cunnane, G. (2001) Amyloid precursors and amyloidosis in inflammatory arthritis Curr. Opin. Rheumatol. 13, 67-73
11. Lemberger, T., Desvergne, B., and Wahli, W. (1996) Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology Annu. Rev. Cell Dev. Biol. 12, 335-363
12. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell 83, 813-819
13. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPAR γ2, a lipid-activated transcription factor Cell 79, 1147-1156
14. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H., and Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell 93, 229-240
15. Francis, G. A., Annicotte, J. S., and Auwerx, J. (2003) PPAR agonists in the treatment of atherosclerosis Curr. Opin. Pharmacol. 3, 186-191
16. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995) 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ Cell 83, 803-812
17. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: New opportunities for drug discovery Nat. Rev. Drug Discovery 3, 401-416
18. Fitzpatrick, F. A. and Wynalda, M. A. (1983) Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro J. Biol. Chem. 258, 11713-11718
19. Yang, M. S., Ji, K. A., Jeon, S. B., Jin, B. K., Kim, S. U., Jou, I., and Joe, E. (2006) Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: Implications for death of activated microglia J. Immunol. 177, 1323-1329
20. Jijon, H. B., Madsen, K. L., Walker, J. W., Allard, B., and Jobin, C. (2005) Serum amyloid A activates NF-κB and proinflammatory gene expression in human and murine intestinal epithelial cells Eur. J. Immunol. 35, 718-726
21. Lee, H. Y., Kim, S. D., Shim, J. W., Lee, S. Y., Lee, H., Cho, K. H., Yun, J., and Bae, Y. S. (2008) Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes J. Immunol. 181, 4332-4339
22. Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter, J. G., Seilhamer, J. J., Vaughan, A. M., and Oram, J. F. (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway J. Clin. Invest. 104, R25-R31
23. Kennedy, M. A., Barrera, G. C., Nakamura, K., Baldan, A., Tarr, P., Fishbein, M. C., Frank, J., Francone, O. L., and Edwards, P. A. (2005) ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation Cell Metab. 1, 121-131
24. Gelissen, I. C., Harris, M., Rye, K. A., Quinn, C., Brown, A. J., Kockx, M., Cartland, S., Packianathan, M., Kritharides, L., and Jessup, W. (2006) ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I Arterioscler., Thromb., Vasc. Biol. 26, 534-540
25. Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., Palinski, W., and Glass, C. K. (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ J. Clin. Invest. 114, 1564-1576
26. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., and Lehmann, J. M. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. U.S.A. 94, 4318-4323
27. Lee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., Chen, J. L., and Li, Y. (2002) T0070907, a selective ligand for peroxisome proliferator-activated receptor γ, functions as an antagonist of biochemical and cellular activities J. Biol. Chem. 277, 19649-19657
28. Chen, C. H., Wang, P. H., Liu, B. H., Hsu, H. H., Mersmann, H. J., and Ding, S. T. (2008) Serum amyloid A protein regulates the expression of porcine genes related to lipid metabolism J. Nutr. 138, 674-679
29. Kisilevsky, R. and Tam, S. P. (2003) Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 J. Lipid Res. 44, 2257-2269
30. Stonik, J. A., Remaley, A. T., Demosky, S. J., Neufeld, E. B., Bocharov, A., and Brewer, H. B. (2004) Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells Biochem. Biophys. Res. Commun. 321, 936-941
31. Tam, S. P., Flexman, A., Hulme, J., and Kisilevsky, R. (2002) Promoting export of macrophage cholesterol: The physiological role of a major acute-phase protein, serum amyloid A 2.1 J. Lipid Res. 43, 1410-1420
32. van der Westhuyzen, D. R., Cai, L., de Beer, M. C., and de Beer, F. C. (2005) Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I J. Biol. Chem. 280, 35890-35895
33. Linsel-Nitschke, P. and Tall, A. R. (2005) HDL as a target in the treatment of atherosclerotic cardiovascular disease Nat. Rev. Drug Discovery 4, 193-205
34. Cai, L., de Beer, M. C., de Beer, F. C., and van der Westhuyzen, D. R. (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake J. Biol. Chem. 280, 2954-2961
35. Cabana, V. G., Feng, N., Reardon, C. A., Lukens, J., Webb, N. R., de Beer, F. C., and Getz, G. S. (2004) Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro J. Lipid Res. 45, 317-325
36. Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T., Csako, G., Thomas, F., Eggerman, T. L., and Patterson, A. P. (2005) Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases J. Biol. Chem. 280, 8031-8040
37. He, R., Sang, H., and Ye, R. D. (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R Blood 101, 1572-1581
38. Zhao, Y., Zhou, S., and Heng, C. K. (2007) Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells Arterioscler. Thromb. Vasc. Biol. 27, 1645-1650
39. Xu, L., Badolato, R., Murphy, W. J., Longo, D. L., Anver, M., Hale, S., Oppenheim, J. J., and Wang, J. M. (1995) A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion J. Immunol. 155, 1184-1190
40. Morrow, J. F., Stearman, R. S., Peltzman, C. G., and Potter, D. A. (1981) Induction of hepatic synthesis of serum amyloid A protein and actin Proc. Natl. Acad. Sci. U.S.A. 78, 4718-4722
41. Cai, H., Song, C., Endoh, I., Goyette, J., Jessup, W., Freedman, S. B., McNeil, H. P., and Geczy, C. L. (2007) Serum amyloid A induces monocyte tissue factor J. Immunol. 178, 1852-1860
42. Walder, K., Kantham, L., McMillan, J. S., Trevaskis, J., Kerr, L., De Silva, A., Sunderland, T., Godde, N., Gao, Y., Bishara, N., Windmill, K., Tenne-Brown, J., Augert, G., Zimmet, P. Z., and Collier, G. R. (2002) Tanis: A link between type 2 diabetes and inflammation? Diabetes 51, 1859-1866
43. Cheng, N., He, R., Tian, J., Ye, P. P., and Ye, R. D. (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A J. Immunol. 181, 22-26
44. Hwang, D., Jang, B. C., Yu, G., and Boudreau, M. (1997) Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: Mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages Biochem. Pharmacol. 54, 87-96